oxybutynin has been researched along with Diabetes Mellitus, Adult-Onset in 9 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In men with hypogonadism and preexisting or a high risk of cardiovascular disease, testosterone-replacement therapy was noninferior to placebo with respect to the incidence of major adverse cardiac events." | 3.30 | Cardiovascular Safety of Testosterone-Replacement Therapy. ( Basaria, S; Bhasin, S; Boden, WE; Chan, A; Cunningham, GR; Davey, D; Dubcenco, E; Flevaris, P; Granger, CB; Huang, B; Kalahasti, V; Khan, N; Khera, M; Li, X; Lincoff, AM; Miller, MG; Mitchell, LM; Nissen, SE; Pencina, KM; Snabes, MC; Thompson, IM; Travison, TG; Wang, Q; Wolski, K; Yi, T, 2023) |
| " This article will review the research progress of MNs in insulin transdermal delivery, including hollow MNs, dissolving MNs, hydrogel MNs, and glucose-responsive MN patches, in which insulin dosage can be strictly controlled." | 2.82 | Microneedle-based insulin transdermal delivery system: current status and translation challenges. ( Lyu, B; Pei, S; Wen, P; Xu, G; Yao, X; Zhao, J; Zhou, H, 2022) |
| "Because oral nonsteroidal anti-inflammatory drugs (NSAIDs) have adverse effects on kidney function, patients with kidney diseases are administered these drugs as transdermal patches." | 2.79 | Safety and efficacy of skin patches containing loxoprofen sodium in diabetic patients with overt nephropathy. ( Araki, H; Araki, S; Isshiki, K; Kashiwagi, A; Kume, S; Kuwagata, S; Maegawa, H; Morita, Y; Soumura, M; Uzu, T; Yamahara, K, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Zhao, J | 1 |
| Xu, G | 1 |
| Yao, X | 1 |
| Zhou, H | 1 |
| Lyu, B | 1 |
| Pei, S | 1 |
| Wen, P | 1 |
| Lincoff, AM | 1 |
| Bhasin, S | 1 |
| Flevaris, P | 1 |
| Mitchell, LM | 1 |
| Basaria, S | 1 |
| Boden, WE | 1 |
| Cunningham, GR | 1 |
| Granger, CB | 1 |
| Khera, M | 1 |
| Thompson, IM | 1 |
| Wang, Q | 1 |
| Wolski, K | 1 |
| Davey, D | 1 |
| Kalahasti, V | 1 |
| Khan, N | 1 |
| Miller, MG | 1 |
| Snabes, MC | 1 |
| Chan, A | 1 |
| Dubcenco, E | 1 |
| Li, X | 1 |
| Yi, T | 1 |
| Huang, B | 1 |
| Pencina, KM | 1 |
| Travison, TG | 1 |
| Nissen, SE | 1 |
| Payne, FW | 1 |
| Ledden, B | 1 |
| Lamps, G | 1 |
| Chen, G | 1 |
| Yu, J | 1 |
| Gu, Z | 1 |
| Ginsberg, BH | 1 |
| Heinemann, L | 1 |
| Waldenmaier, D | 1 |
| Kulzer, B | 1 |
| Ziegler, R | 1 |
| Ginsberg, B | 1 |
| Freckmann, G | 1 |
| Thompson, B | 1 |
| Cook, CB | 1 |
| Araki, H | 1 |
| Kuwagata, S | 1 |
| Soumura, M | 1 |
| Yamahara, K | 1 |
| Morita, Y | 1 |
| Kume, S | 1 |
| Isshiki, K | 1 |
| Araki, S | 1 |
| Kashiwagi, A | 1 |
| Maegawa, H | 1 |
| Uzu, T | 1 |
| Hermanns, N | 1 |
| Lilly, LC | 1 |
| Mader, JK | 1 |
| Aberer, F | 1 |
| Ribitsch, A | 1 |
| Kojzar, H | 1 |
| Warner, J | 1 |
| Pieber, TR | 1 |
4 reviews available for oxybutynin and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Microneedle-based insulin transdermal delivery system: current status and translation challenges.
Topics: Administration, Cutaneous; Diabetes Mellitus, Type 2; Drug Delivery Systems; Humans; Insulin; Needle | 2022 |
Glucose-Responsive Microneedle Patches for Diabetes Treatment.
Topics: Animals; Blood Glucose; Blood Glucose Self-Monitoring; Diabetes Mellitus, Type 1; Diabetes Mellitus, | 2019 |
Patch Pumps for Insulin.
Topics: Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Equipment Design; Humans; Hypog | 2019 |
Patch Pumps: Are They All the Same?
Topics: Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Equipment Design; Humans; Hypog | 2019 |
3 trials available for oxybutynin and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Cardiovascular Safety of Testosterone-Replacement Therapy.
Topics: Aged; Aged, 80 and over; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Double-Blind Method; Ge | 2023 |
Safety and efficacy of skin patches containing loxoprofen sodium in diabetic patients with overt nephropathy.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Blood Pressure; Creatinine; | 2014 |
Novel simple insulin delivery device reduces barriers to insulin therapy in type 2 diabetes: results from a pilot study.
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; In | 2015 |
2 other studies available for oxybutynin and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Capabilities of Next-Generation Patch Pump: Improved Precision, Instant Occlusion Detection, and Dual-Hormone Therapy.
Topics: Algorithms; Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Electrochemistry; E | 2019 |
Insulin Pumping Patches: Emerging Insulin Delivery Systems.
Topics: Clinical Trials as Topic; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Equipment Design; Hu | 2019 |